Long-term central venous access in oncology - Survey of 750 cases;Accessi venosi centrali a lungo termine in oncologia. Revisione di una casistica relativa a 750 casi

Minerva Chirurgica

Volumn 51, Issue 6, 1996, Pages 427-431

  Bertoglio, S ^a,b   Meszsaros, P ^b   Disomma, C ^b   Moresco, L ^a   Cafiero, F ^a   Gipponi, M ^b   Percivale, P ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Central venous access; Infection; Neoplasms; Surgery

Indexed keywords

DACRON;

AMBULATORY SURGERY; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER; CANCER PATIENT; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; FEMORAL VEIN; HUMAN; LIFE EXPECTANCY; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MORBIDITY; ONCOLOGY; OUTPATIENT; PATIENT COMPLIANCE; SUBCLAVIAN VEIN; VASCULAR ACCESS;

EID: 0029795640     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Broadwater JR, Henderson MA, Bell JL et al Outpatient percutaneous central venous access in cancer patients. Am J Surg 1990;160:670-80
2. Hoekstra A, Bassot V, Bertoglio S et al Clinical evaluation of the cordis vascular access Port systems, a multicenter study. Med Oncol Tumour Pharmacother 1993;10(3):131-8.
3. Groeger JS, Lucas AB, Coit D. Venous access in cancer patient. In DeVita VT, Hellman S, Rosemberg SA, editors. Cancer: Principles and Practices of Oncology. 3rd edition Philadelphia: JB Lippincott Co., 1991;5:1-14.
4. Raaf JH Vascular access prostheses in the management of cancer patients. Clin Bull (Memorial Sloan - Kettering Cancer Center) 1980;10:91-101.
5. Raaf JH. Vascular access, catheter technology and infusion pumps. In: Moosa AR, Schimpff SC, Robson MC, editors Comprehensive Textbook of Oncology. 2nd edition. Baltimore. Williams & Wilkins, 1991. 583-9.
6. Alexander HR. Vascular accesses and other specialized techniques of drug delivery. In: DeVita Jr, Hellman S, Rosenberg SA Principles & Practice of Oncology. 3rd ed Philadelphia: JB Lippincott Co., 1991:556-64
7. Moresco L, Meszaros P, DiSomma C et al. Infusione venosa centrale in chirurgia oncologica. Minerva Chir 1993;18:29-31.
8. Moosa HH, Julian TB, Rosenfeld CS, Shadduck RK. Complication of indwelling central venous catheters in bone marrow transplant recipients Surg Gynecol Obstet 1991;172:275-9
9. Pegues D, Axelrod P, McClarren C et al. Comparison of infections in Hickman and implanted Port catheters in adult solid tumor patients. J Surg Oncol 1992;49:156-62.
10. Lazarus HM, Creger RJ, Bloom AD, Shenk R. Percutaneous placement of femoral central venous catheter in patients undergoing transplantation of bone marrow. Surg Gynecol Obstet 1990;170:403-6.
11. Stenzel JP, Green TP, Fuhrman BP, Carlson PE, Marchessault RP. Percutaneous femoral venous catheterization: A prospective study of complication. J Pediatr 1989;114:11-415.
12. Hogan L, Pulito AR. Broviac central venous catheters inserted via the saphenous or femoral vein in the NICU under local anesthesia. J Pediatr Surg 1992;27(9):1185-8.
13. Bertoglio S, DiSomma C, Meszaros P, Gipponi M, Cafiero F, Percivale P Long-term central venous access in femoral vein with implantable Port devices in cancer patients Eur J Surg Oncol, in press 1995
14. Anderson AJ, Krasnow SH, Boyer MW et al. Thrombosis: the major Hickman catheter complication in patients with solid tumor. Chest 1989; 95(1);71-5
15. Bern MM, Lokich JJ, Wallach SR, et al Very low doses of Warfarin can prevent thrombosis in central venous catheters Ann Intern Med 1990;112: 423-8.
16. Lokich JJ, Bothe A, Benotti P, Moore C. Complication and management of implanted venous access catheters. J Clin Oncol 1985;3:710-7.
17. Cohen AM, Wood WC. Simplified technique for placement of long term central venous silicone catheters. Surg Gynecol Obstet 1982;154:721-4.
18. Takasugy JK, O'Connel TX Prevention of complication in permanent central venous catheters. Surg Gynecol Obstet 1988;167 6-11.
19. Groeger JS, Lucas AB, Thaler HT et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993;119(12):1168-74
20. Kaye Cg, Smith DR. Complication of central venous cannulation. Trauma, infection and thrombosis. Br Med J 1988;297(9):573-4.
21. Lokich JJ, Becker B. Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy. Cancer 1983;52:1586-9
22. Sobrero AF, Aschele C, Guglielmi AP et al. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer. Clin Cancer Res 1995;1:955-60.
23. Toma S, Palumbo R, Comandone A et al. Ambulatory 4-day continuous-infusion schedule of high-dose ifosfamide with mesna uroprotection and granulocyte colony-stimulating factor in advanced solid tumours: a phase I study. Ann Oncol 1995; 6:193-6.